APA (7th ed.) Citation

Decoster, L., Aftimos, P., Rottey, S., Prenen, H., Collignon, J., Mebis, J., . . . De Grève, J. (2023). 201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study. Annals of Oncology, 34, S262. https://doi.org/10.1016/j.annonc.2023.09.2924

Chicago Style (17th ed.) Citation

Decoster, L., et al. "201P Afatinib for EGFR, HER2 or HER3 Mutated Solid Tumors: A Phase II Belgian Precision Study." Annals of Oncology 34 (2023): S262. https://doi.org/10.1016/j.annonc.2023.09.2924.

MLA (9th ed.) Citation

Decoster, L., et al. "201P Afatinib for EGFR, HER2 or HER3 Mutated Solid Tumors: A Phase II Belgian Precision Study." Annals of Oncology, vol. 34, 2023, p. S262, https://doi.org/10.1016/j.annonc.2023.09.2924.